Forte Capital LLC ADV Acquires 890 Shares of Bruker Corporation $BRKR

Forte Capital LLC ADV grew its holdings in shares of Bruker Corporation (NASDAQ:BRKR) by 10.2% in the second quarter, HoldingsChannel.com reports. The fund owned 9,615 shares of the medical research company’s stock after purchasing an additional 890 shares during the period. Forte Capital LLC ADV’s holdings in Bruker were worth $396,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Teacher Retirement System of Texas raised its stake in Bruker by 5.1% in the first quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company’s stock valued at $1,212,000 after purchasing an additional 1,422 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of Bruker by 54.2% in the 1st quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company’s stock worth $46,000 after buying an additional 390 shares during the last quarter. Amundi raised its position in shares of Bruker by 373.3% during the 1st quarter. Amundi now owns 42,503 shares of the medical research company’s stock valued at $1,774,000 after buying an additional 33,522 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Bruker by 81.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company’s stock worth $1,245,000 after acquiring an additional 13,367 shares during the last quarter. Finally, OneDigital Investment Advisors LLC grew its position in Bruker by 38.0% in the first quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company’s stock worth $230,000 after acquiring an additional 1,520 shares in the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Insider Buying and Selling at Bruker

In related news, Director Cynthia M. Friend sold 3,535 shares of the company’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $32.25, for a total value of $114,003.75. Following the sale, the director directly owned 18,016 shares of the company’s stock, valued at $581,016. This represents a 16.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 27.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

BRKR has been the subject of several research analyst reports. Jefferies Financial Group set a $60.00 price target on Bruker and gave the stock a “buy” rating in a research note on Monday, August 4th. Bank of America decreased their price objective on Bruker from $61.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. Stifel Nicolaus set a $40.00 target price on Bruker and gave the stock a “hold” rating in a research note on Tuesday, August 5th. Wells Fargo & Company reduced their price target on shares of Bruker from $60.00 to $50.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 5th. Finally, Barclays lowered their price objective on shares of Bruker from $46.00 to $43.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $51.30.

Bruker Trading Up 1.6%

NASDAQ:BRKR opened at $33.31 on Wednesday. The company has a 50-day moving average price of $34.65 and a 200-day moving average price of $38.19. The stock has a market cap of $5.05 billion, a price-to-earnings ratio of 64.06, a P/E/G ratio of 4.56 and a beta of 1.21. The company has a current ratio of 1.61, a quick ratio of 0.70 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 12 month low of $28.53 and a 12 month high of $72.94.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Monday, August 4th. The medical research company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a net margin of 2.31% and a return on equity of 17.89%. The company had revenue of $797.40 million for the quarter, compared to analysts’ expectations of $811.17 million. During the same quarter in the prior year, the firm earned $0.52 EPS. Bruker’s quarterly revenue was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. Equities analysts predict that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, September 23rd. Bruker’s dividend payout ratio (DPR) is presently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.